The Aerospace Medical Association, as part of the 2021 Virtual International Conference in Aerospace Medicine (2021 Virtual ICAM), is offering a two-part webinar series titled "COVID-19 Clinical Impacts and Aeromedical Implications for Aircrew Health and Performance."

The 2021 Virtual ICAM is a series of webinars offered throughout 2021 to replace the ICAM Paris that was postponed from September 2021 to September 2022. The theme of the 2021 Virtual ICAM is "Pandemics and Progress in Aerospace Medicine."

The International Academy of Aviation and Space Medicine (IAASM) is leading the 2021 Virtual ICAM in collaboration with the Aerospace Medical Association (AsMA), the European Society of Aerospace Medicine (ESAM), and La Société Francophone de Médecine Aérospatiale (SOFRAMAS).

Read more ...

COVID-19 : new virus, pandemic and what is expected from vaccination
Prof. Dr. Antonio Cassone, MD

Helping People Perform to Their Best to Inspire the Recovery
Mr. John Franklin - Head of Safety Promotion EASA

In-flight Transmission of SARS-CoV-2: What We Do and Don’t Know
Dr. David O. Freedman, MD - Managing Senior Director, Shoreland Travax and Professor Emeritus of Infectious Diseases, University of Alabama at Birmingham

COVID-19 Vaccines: commercial aviation considerations
Dr. Ian Hosegood MD – Director of Medical Services Quantas, Australia

The United Kingdom (UK) left the European Union (EU) on February 1, 2020. At the time, the EU and the UK agreed on a transition period lasting until December 31, 2020, during which EU law, including EU law on aviation safety, would continue to apply to the UK. The EU and the UK have used this period to negotiate an agreement on their future partnership.

Following negotiations, the European Commission has reached, on December 24, 2020, a trade and cooperation agreement with the United Kingdom on the terms of its future cooperation with the European Union. The Trade and Cooperation Agreement is applied provisionally as of 1 January 2021.

On January 1, 2021 EU aviation safety legislation, including Regulation (EU) 2018/1139 establishing EASA, no longer applies to the UK. As of that date, the UK is considered as a third country and no longer has the status of an ‘EASA Member State’.

Read more ...

Until 31 December 2020, all UK-certificated AMEs, OHMPs and Aeromedical Centres (AeMCs) will continue to be able to issue medical certificates to applicants who hold or are applying for EU licences and cabin crew attestations.

From 1 January 2021, all AMEs, OHMPs and AeMCs for whom the UK is the Competent Authority, will continue to be certificated to perform medical examinations on UK applicants and issue UK PART MED medical certificates and cabin crew medical reports. UK-certificated AMEs wishing to undertake EU medical examinations will have to apply to an EASA member state for third country approval (and/or to EASA for AeMCs).

From 1 January 2021 until 31 December 2022, non-UK EU AMEs (and AeMCs) will only be ‘recognised’ by the UK if the AME (or AeMC) approval certificate was valid on or before 31 December 2020 and had not expired, been suspended or revoked when the medical examination was performed. Examinations and assessments performed by EU OHMPs will not be recognised.

From 1 January 2023 all EU AME, EU OHMP and EU AeMC approval certificates will not be valid for undertaking UK PART MED medical examinations/assessments.

For more details: https://info.caa.co.uk/

The European Society of Aerospace Medicine’s Academy presents its New Year’s online webinar on chances of recovery of the aviation industry in light of the latest aeromedical developments of the COVID-19 pandemic.

Read more ...

Dear Friends and Colleagues,

Over  the past couple of weeks, the Organising Committee of the ICAM 2020 have been considering the viability of the postponement to 2021.

A number of considerations were discussed by the Organising Committee including the following:

• The pandemic continues to be a major threat across Europe and beyond.
• It is unlikely that life will have returned to normal by September of 2021.
• Despite the development of vaccines, there will be a period of time before they are deployed sufficiently to convey herd immunity to the general population.
• Recovery of the Aviation industry and international travel is unlikely to be by September 2021.
• Making a "go, no-go" decision for ICAM 2021 would be required by March 2021 at the latest.
• If we choose to run with 2021 and postpone again, we would lose our deposits whereas deferring to 2022 incurs no extra costs.
• Deferring to 2022 realigns the event with the regular cycle of ECAMs and ICASMs. We will no longer be out of sync.
• Deferring to 2022 allows the new Conferencing company to establish itself and prepare efficiently for the Congress.
• The concept of the ICAM was to bring together members of all four organisations to convene in a physical location and share the experience. Holding a diluted meeting with social distance does not meet with the philosophy of the Congress.
• A virtual meeting was proposed by the Academy in September 2021 which would be virtual and would act as a "taster" for the ICAM 2022 with four sessions presented by each of the four organisations and expressing their own unique character over a two day period using webinars. The Organising Committee supported the proposal and will develop the concept together.

Read more ...

As a result of the COVID-19 global pandemic, the ICAM 2020 Organizing Committee, with representatives from the Aerospace Medical Association (AsMA), the International Academy of Aviation and Space Medicine (IAASM), the European Society of Aerospace Medicine (ESAM), and the Francophone Society of Aerospace Medicine (SoFRAMAS), decided to postpone the 1st International Conference in Aerospace Medicine (1st ICAM). The new dates for the 1st ICAM is now September 22-24, 2022. ICAM 2022 will be conducted at the Centre des Congrès de La Villette in Paris, France.

We are disappointed this first joint meeting of the world's most prominent Aerospace Medicine associations must be postponed, but the health and safety of our Aerospace Medicine colleagues from around the world is our primary concern.

We hope you and your loved ones are all safe, secure, and healthy during this pandemic period. We very much look forward to seeing many of you very soon.


Page 1 of 9